Merck, Glenmark forge Zetia patent settlement; Ranbaxy beats quarterly estimates;

 @FiercePharma: Novartis CEO goes on a 'decluttering' drive. Report | Follow @FiercePharma

> Merck has agreed to let Glenmark Pharmaceuticals sell a generic version of the cholesterol medicine Zetia in the U.S. by December 2016 as part of a settlement of a patent-infringement lawsuit. Release | Report

> India's Ranbaxy Laboratories raced past estimates with its fourth straight quarterly profit and kept ambitious earnings forecasts unchanged for the year. Report

> Drug shortages in the U.K. could remain into next year as parallel traders continue to cash in on the weak pound, according to British Association of European Pharmaceutical Distributors. Report

> Salix Pharmaceuticals' first-quarter loss widened less than it had expected, and the drugmaker also projected a second-quarter profit, which would be its first time in the black in more than two years. Report

> Indian outsourcing provider HCL Technologies has announced a $500 million, five-year deal with Merck, through which HCL will providing BPO, KPO and engineering services. Report

> Purdue Pharma has filed a patent infringement suit against India's Ranbaxy, after the latter applied for marketing approval of a low-cost version of Purdue's pain medicine Oxycodone. Report

Biotech News

 @FierceBiotech: Frenchay Hospital trials offer MS stem cell hopes. Article | Follow @FierceBiotech

 @JohnCFierce:  Tiny Avexa has buried its HIV therapy, demolishing its share price and leaving it scrambling for a survival strategy. Article | Follow @JohnCFierce

> NicOx shares dive after regulators question naproxcinod's benefits. Report

> 'New Merck' spotlights late-stage strategy but shelves biosimilar. Item

> Roche adds $201M in milestones to Galapagos R&D pact. Story

> Test maker's shares soar on GSK cancer pact. Article

> Mayo team discovers new diabetes drug class. News

Manufacturing News

> "Concerned" J&J hopes to stop monthly Tylenol recalls. Story

> Drugmakers: Trypsin likely culprit in Rotavirus vax contamination. News

> Teva, Baxter fined $500M for propofol-vial reuse infections. Report

> Chinese heparin maker's stock falls after strong debut. News

> Findings could aid vax distribution in developing nations. Item

Biotech Research News

> Mayo investigators discover a new class of diabetes drugs. Report

> Aging expert heralds new class of therapeutics. Article

> Senate panel mulls NIH drug development plan. News

> Researchers measure pain in the expressions of lab mice. Story

And Finally... In the race to find answers about ovarian cancer, researchers now have something to cluck about. Report